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Abstract
The idea of implanting microphotodiode arrays as visual prostheses has aroused controversy on its feasibility from the moment
it appeared in print. We now present results which basically support the concept of replacing damaged photoreceptors with
subretinally implanted stimulation devices. Network activity in degenerated rat retinae could be modulated through local electrical
stimulation in vitro. We also investigated the long term stability and biocompatibility of the subretinal implants and their impact
on retinal physiology in rats. Ganzfeld electroretinograms and histology showed no significant side effect of subretinal implants
on retinal function or the architecture of the inner retina. © 1999 Elsevier Science Ltd. All rights reserved.
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1. Introduction
The feasibility of visual prostheses for the blind has
been discussed for many decades. Early concepts of
retinal and cortical implants (Tassiker, 1956; Brindley
& Lewin, 1968; Dobelle, Mladejovsky & Girvin, 1974;
Dawson & Radtke, 1977; Michelson, 1986), some of
which were even tested in human volunteers, proved
unsuccessful due to technical and microsurgical limita-
tions at that time. In the meantime however, amazing
advances in microelectronics have made it possible to
partly replace the inner ear with a quite useful technical
prosthesis: the cochlear implant (Loeb, 1989). This
leads naturally to the question whether corresponding
prostheses which can stimulate retinal neurons electri-
cally and perhaps even restore sight might be feasible
with today’s technology.
New attempts to develop retinal prostheses have
taken different approaches: Some research groups try
to stimulate the ganglion cells and their axons with
epiretinal stimulators which receive signals generated by
an external camera and an external or implanted data
processing system (Narayanan, Rizzo, Edell & Wyatt,
1994; Humayun, de Juan, Dagnelie, Greenberg, Propst
& Phillips, 1996; Wyatt & Rizzo, 1996; Eckmiller, 1997;
Rizzo & Wyatt, 1997). Others have undertaken to
replace lost photoreceptor function with implants for
subretinal stimulation of the retinal network (Chow,
1993; Chow & Chow, 1997; Zrenner, Miliczek, Gabel,
Graf, Guenther & Haemmerle, 1997; Chow, Chow,
Pardue, Perlman & Peachey, 1998; Peyman, Chow,
Liang, Chow, Perlman & Peachey, 1998). Recently, a
new study has lent credibility to the feasibility of a
visual prosthesis for intracortical microstimulation
(Schmidt, Bak, Hambrecht, Kufta, O’Rourke & Vallab-
hanath, 1996), and new types of electrodes which are
suitable for cortical stimulation have been developed
(Normann, Maynard, Guillory & Warren, 1996).
Common to all these approaches is a functional,
electrical multisite stimulation of specific neurons and
neuronal networks. Neuronal activity which is useful
for vision must be evoked under conditions of safe,
chronic charge injection. This requires both knowledge
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of appropriate stimulation parameters and their effects
on neuronal integrity and a familiarity with minimally
invasive implantation techniques and biocompatible
materials which are suitable for long-term implantation
in the eye.
Our group has developed a silicon chip with an
embedded microphotodiode array (MPDA) similar to
that which has been described in several patents by
Chow and associates. When implanted under the retina,
it stimulates adjacent retinal neurons through multisite
injection of photocurrents generated by locally ab-
sorbed light (Fig. 1A).
Histological examination of human donor eyes has
indicated that retinitis pigmentosa retinae still possess a
neuronal network with relatively intact morphology
(Santos, Humayun, de Juan, Greenberg, Marsh, Klock
et al., 1997; Zrenner et al., 1997). We therefore investi-
gated whether the remaining cells of this retinal net-
work can be electrically stimulated in such a way that
useful information will be transmitted to the visual
centers of the brain. Although the answer to this ques-
tion is crucial for the success of any retinal prosthesis,
it clearly cannot be answered by simply implanting a
prototype into the eye of a healthy animal. We there-
fore chose to test the usefulness of MPDA prototypes
for electrical retinal stimulation in vitro by using degen-
erated retinae from Royal College of Surgeons (RCS)
rats. The RCS rat is a well-established animal model
for the study of human retinal degeneration (Sheedlo,
Gaur, Li, Seaton & Turner, 1991a; Kohler, Guenther &
Zrenner, 1997a).
This paper describes the present status of the au-
thors’ work on the crucial issue of subretinal prosthesis
function and its effect on retinal tissue. While the report
focuses primarily on in vitro stimulation experiments
with RCS rat retinae, it also presents the results of our
in vitro biocompatibility tests with cell cultures from
retinae of Brown Norway rats. The long-term tolerance
of implanted chip prototypes was evaluated with
Ganzfeld electroretinograms and histology.
Some of the results described here have been pre-
sented elsewhere in abstract form (Kohler, Hartmann,
Fischer & Zrenner, 1997b; Stett, Weiss, Gnauck, Stel-
zle, Nisch, Haemmerle et al., 1997; Troeger, Guenther,
Schlosshauer, Hoff & Zrenner, 1997; Miliczek, Scholz,
Aramant, Seiler, Tornow, Kohler et al., 1998; Stett,
Kohler, Weiss, Haemmerle & Zrenner, 1998; Weiss,
Herrmann, Kohler, Stett & Haemmerle, 1998).
2. Methods
2.1. Chip technology
Implantable silicon chip prototypes with embedded
MPDAs (Fig. 1B) were fabricated with standard semi-
conductor technology as described previously (Zrenner
et al., 1997; see also the similar technique described by
Peyman et al., 1998). The MPDAs were then supplied
with metallic stimulation electrodes and cut into small
rectangular chips with an area of 0.48–0.8 mm2 and a
thickness of about 50 mm. Details of the chip fabrica-
tion technique will be published elsewhere.
2.2. Functional electrical multisite stimulation in 6itro
Retinae were dissected free from the eye cups of RCS
rats and cut into 55 mm segments. Each segment was
then attached either on the ganglion cell side (Fig. 2A,
B) or the photoreceptor side (Fig. 2C) to a microelec-
trode array (MEA). The MEA consisted of a glass plate
with 60 substrate integrated planar metallic electrodes
of gold [Au] or titanium nitride [TiN]; these were 10 mm
Fig. 1. (Opposite, left) The subretinal approach of a retinal prosthesis. (A) A silicon chip containing an array of individual microphotodiodes
(MPDA, microphotodiode array) is implanted in the subretinal space in an area with degenerated rods and cones. Incident light (arrows from the
left) is absorbed in the photodiodes and generates current in direct proportion to the local intensity of the light. Via the metallic stimulation sites
the current is injected into the retinal tissue (small bundles of arrows from the right). Therefore at the distal side of the retina a spatiotemporal
charge injection pattern is generated by multisite light-to-current-conversion. (B) Light-microscopic view of a small area of the chip. The light
sensitive area of a single microphotodiode is 625 mm2. Each diode has its own stimulation electrode on its center (gold, square size: 88 mm).
Fig. 2. (Opposite, right) Functional electrical retina stimulation in vitro. (A) Sandwich preparation technique: pieces of whole mount retinae are
attached to a microelectrode array (MEA) with the ganglion cell side facing the transparent glass plate and its embedded planar electrodes (*).
The MPDA prototype chips are then placed onto the retina and illuminated with flashes of light (arrow from bottom). Multi-unit ganglion cell
activity (spikes) evoked by the light generated photodiode current (arrows from top) is recorded with several MEA electrodes in parallel. (B)
Monofocal distal current injection: a tungsten electrode is lowered into the distal side of the retina. Monopolar charge balanced current pulses
of different duration and strength are applied. (C) Multisite charge injection: with the ganglion cell side up, multifocal stimulation of the distal
retina side is obtained by applying voltage pulses to a variable number of electrodes of the MEA. The retinal response is recorded from ganglion
cell bodies with a glass pipette. (D) Histological cross section of a retina piece of a 194-day-old RCS rat that had previously been put on a MEA
and electrically stimulated for about 6 h. At that age the entire photoreceptor layer has disappeared from the RCS rat retina and only a debris
layer (*) with some scattered cell bodies can be found proximal to the inner retina. In contrast, the architecture of the inner retina is well preserved
and all layers, i.e. INL, IPL, GCL, are present. (E) Spontaneous activity of a ganglion cell in a 185-day-old RCS rat retina (top: rasterplot of 20

















Fig. 1. Caption opposite.
Fig. 2. Caption opposite.
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Fig. 3. Response histograms of electrically evoked spike activity of ganglion cells in RCS rat retinae. (A) Sandwich test: the MPDA (monopolar
pin diodes, size 2020 mm2) was illuminated with pulses of white light (retinal illuminance: 70 kLux, pulse duration 500 ms, pulse onset at time
0 ms, spot diameter 250, 500, 1000 mm). Histograms were obtained from single unit recordings of 60 subsequent trials, bin width 10 ms; retina
from a 229-day-old animal. (B) Monofocal current stimulation with charge balanced current pulses against ground electrode (rectangular pulse
at time 0 ms, duration 1 ms, followed by an exponential discharging phase, amplitude as indicated). Shown are histograms (60 trials, bin width
3 ms) from unsorted multi unit recordings underneath the stimulation site (left column, 0 mm), and 100 mm (middle column) and 300 mm (right
column) apart from the current injection site; retina from a 81-day-old animal (details see text). (C) Multisite charge injection with monophasic
voltage pulses against ground electrode (1 V, duration 500 ms) applied at time 0 ms to the MEA electrodes indicated by filled circles in the inserted
maps; histograms (50 trials, binwidth 10 ms) obtained from spike recordings of a ganglion cell body located above the marked electrode in the
left map; retina from a 132-day-old animal.
in diameter and were spaced 100 and 200 mm apart,
respectively. A circular chamber was centered on the
recording area as described by Nisch, Bo¨ck, Haemmerle
and Mohr (1994). These chambers containing the re-
spective retinal preparation were constantly perfused
with oxygenated standard perfusate at 35°C.
The so-called Sandwich preparation technique (Fig.
2A) was used to test MPDA prototypes in vitro as
described previously (Zrenner et al., 1997). In this test,
the distal retina was electrically stimulated by sending
flashes of either white or infrared light through the
glass substrate of the MEA onto a MPDA located on
the distal retina. In a second set of experiments with the
ganglion cell side down, monopolar current pulses were
applied to the distal retina via a needle microelectrode
positioned on the receptor layer, and the spike activity
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of retinal ganglion cells was recorded with the MEA
electrodes (Fig. 2B). In a variation of this technique
with the receptor side down, the distal retina was
stimulated by applying voltage pulses via selected MEA
electrodes (Fig. 2C). The spike activity evoked by these
spatial stimulus patterns in individual ganglion cell
bodies was recorded extracellularly by means of a glass
electrode.
2.3. Biocompatibility of chip materials
Retinal cell cultures were prepared from
enzymatically and mechanically disrupted retinae of
4–12 day old Brown Norway rats as described
elsewhere (Guenther, Rothe, Taschenberger & Grantyn,
1994). The cells were plated with a density of 3500
cells:mm2 either directly on different technical
substrates or on glass cover slips for comparison and
were then incubated at 37°C and 5% CO2 for up to 4
weeks. The substrates were coated with poly-L-lysine.
ARAC (arabinosylcytosine-hydrochloride, 1 mM) was
added after 4 days to stop mitosis. The cell cultures
were fixed in 4% paraformaldehyde after 1, 7, 21, and
28 days in vitro. Cell nuclei were labeled by DAPI
staining, and the actin containing cytoskeleton was
labeled with Phalloidin-TRITC. Neurones can be
separated from glia cells by this method due to the
smaller size of their nuclei (Fig. 4A). Viable cells from
the different cell types were recorded under a
fluorescence microscope as the mean values of ten
randomly selected areas. The toxicity of different
materials and diffusible factors were tested by
registering either the percentage of viable cells in direct
contact with the technical materials or the percentage
of viable cells in a culture dish containing the different
materials.
2.4. Implantation techniques
For implantation into rat eyes a different tool and
procedure were developed than those described previ-
ously (Zrenner et al., 1997). The implant was no longer
injected or pushed into place (Seiler & Aramant, 1999).
Rats (10 Sprague-Dawley and 15 Long-Evans rats) were
anesthetized with intraperitoneal injections of sodium
pentobarbital (38–40 mg:kg) and atropine (0.4 mg:kg),
followed by xylazine (3–7 mg:kg) 10 min later. A small
incision (0.5–1.0 mm) was made just through the sclera,
choroid and retina behind the pars plana and parallel to
the limbus. Microchips were loaded into the custom-
made implantation tool, which was then used to insert
the microchip into the subretinal space (Fig. 5A). Most
of the implants were placed in the superior quadrant of
the rat eye (Fig. 5B). After implantation, the incision was
closed with 10–0 sutures. The animals were treated
according to the regulations in the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research
and the National Institutes of Health Guide for the Care
and Use of Laboratory Animals.
2.5. Electrophysiological function testing in 6i6o
Rats were anesthetized with intraperitoneal injections
of ketamine (100 mg:kg) and xylazine (15 mg:kg). A
TOENNIES MULTILINER with a Ganzfeld stimulator
(white light) or custom-made LED stimulator (white or
infrared light, respectively) was used. Corneal electrodes
made of gold wire were used for electroretinogram
(ERG) recordings. Subcutaneous steel needle electrodes
were used as reference and ground electrodes. High
frequency (low pass) filters were set to maximum frequen-
cies (5 or 20 kHz) to detect the fast potentials created by
illuminated MPDAs.
2.6. Histology
The eyes were enucleated after decapitation of the rats.
Subsequently they were opened along the ora serrata, and
the posterior eye cups were immediately fixed for 2 h in
4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4.
To examine the retina overlying an implanted device, the
tissue was carefully removed from the implant and either
embedded in methacrylate (Technovit 7100, Heraeus,
Germany) or prepared for immunohistology. From the
methacrylate blocks 2 mm sections were cut, mounted on
slides, stained with toluidine blue and microscopically
examined. For the immunostaining the fixed retina was
immersed in 30% sucrose in phosphate buffered saline,
embedded in mounting medium, and frozen. Cryo-sec-
tions of 12 mm were collected on gelatin coated slides.
After pre-incubation in a solution of 20% normal goat
serum, standard immunohistochemistry was carried out
with an antibody against glia fibrillary acidic protein
(GFAP; Sigma, Germany) diluted 1:500 in 0.05 M
phosphate buffered saline, 0.03% Triton X-100; the
immunoreaction was visualized with a fluorescent chro-
mogen. Cell nuclei were occasionally counterstained with
DAPI (4,6-diamidino-2-phenylindole).
3. Results
3.1. Functional electrical stimulation of degenerated
retinae in 6itro
Spontaneous activity in the retinal networks of the
degenerated retinae was determined by means of the
arrangements shown in Fig. 2A–B. Regardless of the
stage of degeneration, the ganglion cells displayed a
relatively high spontaneous activity of up to 48 Hz as
shown in Fig. 2E. This was true of all retinae examined
so far (n20, postnatal age from 80 to 230 days). None
Fig. 4. Caption opposite.
Fig. 5. Caption opposite.
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of the retinae exhibited any response in relation to
stimulation with visible light.
Beams of white light were flashed onto MPDAs on
the distal side of degenerated retinae in order to test for
ganglion cell activity under electrical stimulation of
retinal cells with photocurrents from an MPDA proto-
type (Fig. 2A). Following the onset of light incidence,
an inhibition of spontaneous ganglion cell activity was
observed in the peristimulus time histograms at retinal
illuminances between 10 and 100 kLux (Fig. 3A). This
inhibition increased to saturation level as the diameter
of the stimulating light spot widened from 250 to 1000
mm. Even at exceptionally high illuminances of 70
kLux, no modulation of activity was detectable under
small light spots which illuminated only a few mi-
crophotodiodes of the array.
Local electrical excitability of the retinae was tested
with focal current injection using a needle electrode
lowered onto the distal retina as shown in Fig. 2B.
Multichannel recordings of spike activity revealed a
clear correlation between the strength of stimulation
and the local retinal response at distances of 0, 100 and
300 mm from the stimulation site, as shown in Fig. 3B.
Control measurements without electrical stimulation
are shown in the upper row of Fig. 3B, while the middle
row and lower row present the data recorded after
stimulation with low (10 mA) and high (50 mA) current
amplitude, respectively. A current pulse of 10 mA am-
plitude and 1 ms duration beneath the site of current
injection (0 mm) provided a clear suprathreshold stimu-
lus, resulting in a short but clear transient inhibition of
spontaneous activity. A further increase in current am-
plitude to 50 mA increased the firing rate at the site of
stimulation (0 mm). The same current pulse of 50 mA
also resulted in a clear inhibition at recording sites 100
and 300 mm from the location of charge injection (Fig.
3B, third row).
In a further series of experiments we used the MEAs
for distal multifocal charge injection. This arrangement
(see Fig. 2C) corresponded very well to multisite stimu-
lation with the individual planar stimulation electrodes
of the MPDA. Applying voltage pulses to the metallic
electrodes resulted in a time course of the injected
current very similar to that obtained by MPDAs
flashed with light. Again, the application of a single
voltage pulse elicited a temporal inhibition of cell firing
Fig. 6. Long term functional stability and tolerance of implanted
MPDAs. (A) Electroretinogram (ERG) of an implanted eye 14
months after implantation of a MPDA. The upper curve shows a
normal ERG waveform after full field stimulation with white light (8
mW:cm2) from a LED. After stimulation with an infrared LED (300
mW:cm2) the chip response is recorded which corresponds to the
duration of the stimulus in both cases. (B) Time courses of ampli-
tudes and latencies of Ganzfeld-ERGs of implanted eyes with refer-
ence to the values obtained from the eye without implant (top:
implant size: 0.81.0 mm, location see corresponding fundus pho-
tograph in Fig. 5; bottom: implant size: 0.651.0 mm).
Fig. 4. (Opposite, top) Biocompatibility of four different chip materials: silicon oxide (SiO2), iridium (Ir), silicon nitride (Si3N4) and titanium
nitride (TiN). (A) Retinal cell culture on a MPDA followed up for 28 days: cells were labelled by a combined cytoskeleton:cell nuclei staining.
Large, faint blue cell nuclei are those of glia cells; small, white blue nuclei those of retinal neurons. (B) Cell survival of retinal cells cultured on
different implant materials. (C) Test for toxicity of diffusible factors of TiN. A reduced cell survival can only be seen for retinal cells in direct
contact with TiN material.
Fig. 5. (Opposite, bottom) Rat implantation technique. (A) A small incision (0.5–1.0 mm) is cut in the pars plana or just behind, parallel to the
limbus. MPDAs are loaded into a custom-made implantation tool, which inserts the chip into the subretinal space. (B) Fundus photograph 229
days after implantation. The implant (arrow) is located perfectly in the subretinal space.
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rates, followed by a time interval with increased spike
activity when the amplitude of the applied pulse was
increased up to 2 V (data not shown). As shown in Fig.
3C this behaviour of the retinal network was also
evoked by increasing the stimulated retinal area sur-
rounding the recording site, and by applying the
voltage pulses to an increasing number of electrodes
and was most pronounced when large areas were stimu-
lated (Fig. 3C, right).
3.2. Biocompatibility of implant materials
The survival of retinal neurons cultured on or in
close vicinity to different substrates of a MPDA was
tested as a means of evaluating the biocompatibility of
potential chip materials. Fig. 4 shows the results of
such an analysis of SiO2 and Si3N4 (used as insulators)
and Ir and TiN (used as electrode materials). Most of
the materials tested had good biocompatibility (Fig.
4B), and there was no significant difference in cell
survival from that of the control group (P0.001, data
not shown here). TiN, however, showed a different
biocompatibility. After 4 weeks, only 3095% of the
control cells had survived in direct contact with this
material (Fig. 4C, white bars) whereas no significant
difference from the control groups was found in retinal
cells cultured in a dish containing TiN. Thus, no solu-
ble factor of the TiN material is responsible for this
effect.
3.3. Surgical procedures
Due to the smallness of the rat eye and its large lens
(Fig. 5A), implantation of the MPDAs was difficult
with conventional methods. We therefore chose to use
the elegant implantation technique devised by Aramant
and Seiler (see Section 2), which makes it possible to
insert relatively large MPDAs as shown in Fig. 5B.
3.4. Long-term function and tolerance of the implant
Long-term function the MPDAs were measured elec-
trophysiologically at different times after implantation.
An original response to white light and infrared light
(which alone is seen by the MPDA) is shown in Fig. 6A
for comparison. After a total of 20 months after im-
plantation the chip response to illumination still re-
mained essentially stable. No electrically evoked retinal
potential in vivo was unambiguously due to postrecep-
toral neurons, despite external infrared light intensities
up to 180 mW:cm2. This was possibly due to the fact
that the area of the retina stimulated by the MPDA is
very small and thereby the postreceptoral neuronal
response itself is disguised by the high discharge re-
sponse of the MPDA. To test the impact of the im-
planted MPDA on retinal physiology, ERGs were
recorded simultaneously in both eyes up to 229 days
after implantation in five normally pigmented rats
(Long Evans) which had received a microphotodiode
array in one eye. Two examples are shown in Fig. 6B.
Amplitudes (solid lines) and implicit times (dotted lines)
of the b-waves of the implanted eyes were compared to
those of control eyes which had not received an im-
plant. Although the b-wave amplitudes were reduced in
some cases (3:5), the implicit time was never affected
(Fig. 6B). This indicates that the number of photore-
ceptors was slightly reduced, but that the function of
photoreceptors was not affected.
3.5. Histology after implantation
More than 4 months after the implantation of MP-
DAs with an area of 0.48–0.8 mm2 and a thickness of
50 mm, the architecture of the rat retina directly above
the MPDA was still intact (Fig. 7A). Only a few
remaining cell bodies of the outer nuclear layer (ONL)
were found between the implant and the retina. Parts of
the outer plexiform layer (OPL) were still detectable
with the light microscope, even though the OPL had
become atrophic after the photoreceptors completely
disappeared. The thickness of the inner nuclear layer
(INL) and the inner plexiform layer (IPL) was un-
changed, and the number of cells in the INL and the
ganglion cell layer (GCL) was essentially the same
outside and above the implant. We do not know at
present whether all neuronal cell types are preserved in
a similar way and whether single neurons in the INL
may be replaced by glia cells. However, the undisturbed
stratification of the inner retinal layers makes prolifera-
tion of Mu¨ller glia rather unlikely. After an implanta-
tion period of 8 months, the longest period examined
until now in a rat retina, immunoreactivity for GFAP
(glia fibrillary acidic protein) was enhanced in the
Mu¨ller cells, indicating that alterations in protein ex-
pression occur even when standard histology is normal
(Fig. 7B). In addition, enhanced numbers of cells were
observed in the GCL and the ganglion cell fiber layer in
some areas of the retina; this was probably due to the
proliferation of astrocytes. The pattern of proliferation
at the vitreal side of the retina was irregular, and
proliferation was restricted to a few areas 40–100 mm in
diameter. Proliferation on the vitreal side also corre-
sponded to an intense GFAP-staining at the level of the
former OPL. It is unclear whether this glial prolifera-
tion was caused by an injury during surgery, by an
irregularity on the surface of the microphotodiode, due
e.g. to handling during implantation, by a specific
morphological or physiological situation of the retina,
e.g. a large epiretinal vessel, or whether it represented
gliotic hot spots with a tendency to progressive growth.
However, no glia encapsulation of the implant was
observed.
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Fig. 7. Histologic cross sections of retinal implantation sites. (A) Rat retina overlaying a subretinally implanted MPDA after more than four
months of implantation. The former outer nuclear layer is reduced to a single row of cell bodies (arrows) but the architecture of the inner retina
is well preserved. (B) GFAP immunoreactivity in a rat retina overlying a subretinally implanted MPDA after eight months of implantation. There
is a massive upregulation of GFAP immunoreactivity (red) in the Mu¨ller cells. Note the enhanced number of cell nuclei (blue; DAPI staining) in
the ganglion cell layer and the optic fiber layer which is probably due to the proliferation of astrocytes. INL, inner nuclear layer; IPL, inner
plexiform layer; GCL, ganglion cell layer; FL, optic fiber layer. Scale bar 25 mm.
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4. Discussion
4.1. Functional electrical stimulation of degenerated reti-
nae in 6itro
Several groups of researchers have shown that it is
possible to evoke phosphenes by electrical stimulation of
degenerated retinae (Potts, Inoue & Buffum, 1968;
Miyake, Yanagida & Yagasaki, 1981; Kato, Saito &
Tanino, 1983). In these experiments, contact lens elec-
trodes were used to elicit something like a full-field
electrical response of the visual system. Although these
results are highly intriguing because they demonstrate
basic possibility of eliciting visual sensation by means of
electrically mediated retinal responses in blind subjects,
it remains unknown whether spatial resolution can be
achieved by focal electrical stimulation of either the distal
or proximal side of the retina. Humayun et al. were the
first to use focal electrical stimulation of degenerated
retinae of human volunteers to investigate the feasibility
of a retinal prosthesis with pixelized visual input (Hu-
mayun et al., 1996). They inserted stimulating probes
with two or three electrodes, respectively, through the
sclera to deliver current to the retinal surface. Although
the subjects were able to localize and resolve evoked
phosphenes, such experiments have drawbacks. First, the
exact distance between the electrodes and the retinal
surface is unknown. Second, intraoperative retinal stim-
ulation experiments in human volunteers involves risks
such as that of intraocular infections. To circumvent
these problems, we have developed in-vitro methods for
investigating basic issues related to functional electrical
multisite stimulation of normal and degenerated retinal
networks.
We found that intrinsic spontaneous ganglion cell
activity is present even in a highly degenerated retinal
network and that it can be modulated by local electrical
stimulation. This is important for all approaches to a
visual prosthesis, because it is now certain that output
neurons of the retina are still able to transmit information
to higher visual centers. This intrinsic activity also
constitutes an important noise background against which
electrically evoked signals carried by the cell must be
detected. This is also true of visual signals transmitted in
intact retinae, as Troy et al. have emphasized (Troy &
Robson, 1992; Troy & Lee, 1994).
Our results clearly indicate that stimulus-related activ-
ity can be evoked even in highly degenerated retinal
networks, thus permitting modulation of firing rate of
ganglion cells depending on the amount and spatial
extent of the distally injected charge. The geometry of the
stimulation electrode (needle vs. planar electrode) is
apparently unimportant for the stimulation of retinal
cells. Excitation thresholds in this study, typically up to
10109 C per balanced pulse and monopolar elec-
trode injected into the subretinal space (Fig. 3B), were
far below those reported by other authors who stimulated
degenerated retinae from the vitreal side (Humayun et
al., 1996; Katona, Humayun, de Juan, Suzuki, Weiland
& Greenberg, 1998). This might be due to the fact that
we used a much shorter distance between the stimulation
electrode and the excited neuronal tissue. The authors
just mentioned also point out that they stimulated cells
of the inner nuclear layer from the epiretinal side
(Greenberg, Humayun & de Juan, 1998); in comparison
to direct subretinal stimulation of these cells, this may
also have resulted in an increase of stimulation
thresholds.
4.2. Biocompatibility of implant materials
Our results showed that retinal cells can be cultured
on materials intended for use in MPDA implants.
Although most of implant materials used in this study
had good biocompatibility, cells which had direct contact
with TiN had a shorter survival time. This is unfortunate,
since TiN electrodes have the greatest safe charge injec-
tion capacity of all electrode materials examined so far
(Janders, Egert, Stelzle & Nisch, 1996), because of their
exceptionally high capacity and columnar surface design.
Since relatively high charge densities are needed for
threshold stimulation of retinal cells, and the largest
possible operating range below the safe charge injection
limit is desirable for a retinal implant, a compromise
between the needs for the best stimulation electrodes and
the biocompatibility of electrode materials had to be
found. However, it is clear that no soluble factor is
responsible for the decreased cell survival. Hence, no
release of toxic substrates is expected from subretinally
implanted chips made of the materials tested so far.
4.3. Histology after implantation
An implanted microchip in the subretinal space forms
a diffusion barrier between the retinal pigment epithe-
lium (RPE) and the retina. This reduces metabolic
interactions between the RPE and the neuronal retina,
and degeneration may be the result within the neuronal
network. In species with well vascularized retinae an
appropriate supply of the inner parts of the retina can
be maintained without diffusion via the RPE, such
retinae should be therefore less affected by an implant.
Similar to the human retina, the rat retina has epiretinal
as well as intra-retinal vessels which run through all
retinal layers terminating below the photoreceptor
synapses in the outer plexiform layer.
Histology showed that the implants were well tolerated
for eight months and did not alter the neuronal architec-
ture of the inner retina. However, immunohistochemistry
for GFAP clearly showed that the Mu¨ller glia was
affected by the implant. Mu¨ller cells do not normally
express GFAP, but upregulation of GFAP expression is
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a common event during degeneration of the retina
irrespective of the etiology of the degeneration. Increased
GFAP immunoreactivity in Mu¨ller cells has been ob-
served in response to retinal injury, including retinal light
damage (Eisenfeld, Bunt-Milam & Sarthy, 1984; Burns
& Robles, 1990), inherited retinal degeneration (Ek-
stro¨m, Sanyal, Narfstro¨m, Chader & van Veen, 1988;
Sarthy & Fu, 1989; Smith, Brodjian, Desai & Sarthy,
1997) and induced retinal injury (Seiler & Turner, 1988;
Tyler & Burns, 1991). Therefore, if a device is implanted
into a degenerated retina a reactive Mu¨ller glia will
already be present. For a proper function, the implant
has to deal with this phenomenon.
Conclusive information about the histological situa-
tion at the implant-tissue interfaces can only be obtained
when the silicone chip is examined in situ. To this end
we are currently developing new techniques for section-
ing the technical device together with the biological tissue
which adheres to it.
4.4. Long-term tolerance and function of the implant
Because of the high retinal illuminances required to
evoke recordable network activity with MPDAs (cf. Fig.
3A), we concentrated our electrophysiological in vivo
experiments on the question whether passive MPDAs
maintain a good long-term function in the silicon-hostile
environment of the subretinal space and are tolerated by
the neuronal network. Others have addressed this ques-
tion as well (Chow & Chow, 1997; Peyman et al., 1998)
and have found results comparable to ours, although
different animal models and surgical methods were used
in these investigations.
The slightly reduced ERG b-wave amplitudes in some
preparations may have been due in part to the implan-
tation technique. Despite extreme caution some retinal
lesions may have occurred, since the surgeon was unable
to observe his manipulations and therefore could not
precisely assess final localization of the implant during
the operation. The implanted chips were 50 mm thick,
rigid, and did not adapt to the curvature of the eye. Injury
to the host retina might be reduced by implanting
thinner, flexible chips like those presently being devel-
oped by Schubert, Hierzenberger, Wanka, Graf, Graf
and Nisch (1997). Another reason might be degeneration
of the photoreceptors underneath the implant as revealed
by histology. The photoreceptor degeneration was most
likely caused by the fact that the chip was not perforated;
this reduced the transport of nutrients from the choroid
to the outer retina. Thinner, flexible and better designed
chips with openings to allow diffusion should alleviate
these problems.
Thus far it has not been possible to record retinal
potentials which were electrically evoked by the MPDA
in rats. Electrically evoked cortical potentials have been
recorded, however, in rabbits by infrared stimulation of
the MPDA. Unfortunately such experiments can not be
performed in rats with presently available technology.
4.5. The future of subretinal microphotodiodes as 6isual
prostheses
Both in vitro and in vivo, we found that retinal
illuminance above naturally occurring levels is needed to
generate local photocurrents in high enough quantities to
successfully stimulate the retinal network by means of the
MPDA. Various concepts are now being developed to
provide additional energy to subretinally implanted chips
from an external power supply.
Is it really possible to replace degenerated photorecep-
tors with subretinally implanted microphotodiodes? Our
experiments with degenerated retinae clearly indicate
that the answer is yes. We think that basic questions
regarding functional electrical multisite stimulation of
degenerated retinae, the biocompatibility of implant
materials, surgical procedures, and the long term func-
tion of implants have now basically been answered. This
opens up promising perspectives for future work in this
field. Future experiments will need to implant chips in
animal models with retinal degeneration, such as the
RCS rat, and then address the question whether the
degenerated retina can respond to the chip in vivo as well
as has been shown in vitro in the present paper. However,
much work remains to be done in fields like the develop-
ment of a MPDA with external power supply before the
implantation of MPDAs in patients suffering from
photoreceptor loss seems appropriate.
Acknowledgements
The authors are very indebted to the following collab-
orators, who have done a great deal of work in various
areas. The MPDAs were manufactured at the Institute
for Micro-Electronics, Stuttgart (Head: B. Hoefflinger)
by M. Graf and H.G. Graf and at the Institute for
Physical Electronics, Stuttgart (M. Schubert). Supplying
the MPDAs with metallic stimulation sites and sizing and
testing them was carried out at the Natural and Medical
Sciences Institute, Reutlingen (NMI, Department Ap-
plied Physics, Head: W. Nisch) by B. Brunner, V. Bucher,
P. Gnauck and M. Stelzle. J. Hartmann, S. Scholz and
B. Tro¨ger from the University Eye Hospital, Tuebingen
and B. Schloßhauer (NMI) contributed in the areas of
histology, in vivo testing, and biocompatibility; W.
Barth, T. Herrmann and M. Tepfenhart assisted in the
in vitro experiments at the NMI. B. Perez, B. Kalinowska
and K. Volk were involved in the implantation proce-
dures at the Univ. of Louisville. We are very grateful to
A. Chow and N. Peachey as well as to V.-P. Gabel, Sacks
and K. Kobuch for valuable discussions. For further
information see http:::www.uni-tuebingen.de:subret.
E. Zrenner et al. : Vision Research 39 (1999) 2555–25672566
This study is supported by grants from the German
Federal Ministry of Education, Science, Research and
Technology (BMBF) No. 01 IN 502 A-D; NIH grant
EY08519; fortu¨ne grant no. 233, University Tuebingen;
the German Humboldt Foundation; the Vitreoretinal
Research Foundation, Louisville; the Murray Founda-
tion Inc.; a grant from the Research to Prevent Blind-
ness and from the Pro Retina Germany Foundation; by
technical device support by Hewlett Packard GmbH,
Boeblingen:Germany; and funds from an anonymous
sponsor.
References
Brindley, G. S., & Lewin, W. S. (1968). The sensations produced by
electrical stimulation of the visual cortex. Journal of Physiology,
196, 479–493.
Burns, M. S., & Robles, M. (1990). Muller cell GFAP expression
exhibits gradient from focus of photoreceptor light damage. Cur-
rent Eye Research, 9, 479–486.
Chow, A. Y. (1993). Electrical stimulation of the rabbit retina with
subretinal electrodes and high density microphotodiode array
implants. In6estigati6e Ophthalmology and Visual Science, 34, 835
(Abstract).
Chow, A. Y., Chow, V. Y., Pardue, M. T., Perlman, J. I., & Peachey,
N. S. (1998). Retinal and cortical potentials induced by subreti-
nally implanted microphotodiode arrays. In6estigati6e Ophthal-
mology and Visual Science, 39, S565 (Abstract).
Chow, A. Y., & Chow, V. Y. (1997). Subretinal electrical stimulation
of the rabbit retina. Neuroscience Letters, 225, 13–16.
Dawson, W. W., & Radtke, N. D. (1977). The electrical stimulation
of the retina by indwelling electrodes. In6estigati6e Ophthalmology
and Visual Science, 16, 249–252.
Dobelle, W. H., Mladejovsky, M. G., & Girvin, J. P. (1974). Artificial
vision for the blind: electrical stimulation of visual cortex offers
hope for a functional prosthesis. Science, 183, 440–444.
Eckmiller, R. (1997). Learning retina implants with epiretinal con-
tacts. Ophthalmic Research, 29, 281–289.
Eisenfeld, A. J., Bunt-Milam, A. H., & Sarthy, P. V. (1984). Muller
cell expression of glial fibrillary acidic protein after genetic and
experimental photoreceptor degeneration in the rat retina. In6es-
tigati6e Ophthalmology and Visual Science, 25, 1321–1328.
Ekstro¨m, P., Sanyal, S., Narfstro¨m, K., Chader, G. J., & van Veen,
T. (1988). Accumulation of glial fibrillary acidic protein in Muller
radial glia during retinal degeneration. In6estigati6e Ophthalmol-
ogy and Visual Science, 29, 1363–1371.
Greenberg, R. J., Humayun, M. S., & de Juan, Jr., E. (1998).
Different cellular time-constants allows selective electrical stimula-
tion of retinal neurons. In6estigati6e Ophthalmology and Visual
Science, 39, S903 (Abstract).
Guenther, E., Rothe, T., Taschenberger, H., & Grantyn, R. (1994).
Separation of calcium currents in retinal ganglion cells from
postnatal rat. Brain Research, 633, 223–235.
Humayun, M. S., de Juan, Jr., E., Dagnelie, G., Greenberg, R. J.,
Propst, R. H., & Phillips, D. H. (1996). Visual perception elicited
by electrical stimulation of retina in blind humans. Archi6es of
Ophthalmology, 114, 40–46.
Janders, M., Egert, U., Stelzle, M., & Nisch, W. (1996). Novel thin
film micro-electrodes with excellent charge transfer capability for
cell stimulation and sensing applications. Proceedings of the 18th
Annual International Conference. IEEE Engineering and Medical
Biology Society c364.
Kato, S., Saito, M., & Tanino, T. (1983). Response of the visual
system evoked by an alternating current. Medical and Biological
Engineering and Computing, 21, 47–50.
Katona, S. J., Humayun, M. S., de Juan Jr., E., Suzuki, S., Weiland,
J. D., & Greenberg, R. J. (1998). A comparison of electrical
stimulation thresholds in normal versus degenerated (rd) mouse
retina. In6estigati6e Ophthalmology and Visual Science, 39, S991
(Abstract).
Kohler, K., Guenther, E., & Zrenner, E. (1997a). Tiermodelle in der
Retinitis-pigmentosa-Forschung. Klinische Monatsbla¨tter fu¨r Au-
genheilkunde, 211, 84–93.
Kohler, K., Hartmann, J., Fischer, S., & Zrenner, E. (1997b). Degen-
erative processes in the inner retina of the RCS rat. In6estigati6e
Ophthalmology and Visual Science, 38, S38 (Abstract).
Loeb, G. E. (1989). Neural prosthetic interfaces with the nervous
system. Trends in Neuroscience, 12, 195–201.
Michelson, R.P. (1986). Method and apparatus for visual prosthesis.
US Patent No. 4,628,933.
Miliczek, K.-D., Scholz, S., Aramant, R. B., Seiler, M. J., Tornow, R.
P., Kohler, K., & Zrenner, E. (1998). Subretinal microphotodi-
odes in rat eyes: biocompatibility, electroretinography and im-
plantation technique. In6estigati6e Ophthalmology and Visual
Science, 39, S565 (Abstract).
Miyake, Y., Yanagida, K., & Yagasaki, K. (1981). Visual function
proximal to the photoreceptors in primary retinitis pigmentosa.
Folia Ophthalmolica Japanese, 32, 302–308.
Narayanan, M. V., Rizzo, J. F., Edell, D., & Wyatt, J. (1994).
Development of a silicon retinal implant: cortical evoked poten-
tials following focal stimulation of the rabbit retina with light and
electricity. In6estigati6e Ophthalmology and Visual Science, 35,
S1380 (Abstract).
Nisch, W., Bo¨ck, J., Haemmerle, H., & Mohr, A. (1994). A thin film
microelectrode array for monitoring extracellular neuronal activ-
ity in vitro. Biosensors and Bioelectronics, 9, 737–741.
Normann, R. A., Maynard, E. M., Guillory, K. S., & Warren, D. J.
(1996). Cortical implants for the blind. IEEE Spectrum, 33, 54–
59.
Peyman, G., Chow, A. Y., Liang, C., Chow, V. Y., Perlman, J. I., &
Peachey, N. S. (1998). Subretinal semiconductor microphotodiode
array. Ophthalmic Surgery and Lasers, 29, 234–241.
Potts, A. M., Inoue, J., & Buffum, D. (1968). The electrically evoked
response of the visual system (EER). In6estigati6e Ophthalmology
and Visual Science, 7, 269–278.
Rizzo, J. F., & Wyatt, J. (1997). Prospects for a visual prosthesis. The
Neuroscientist, 3, 251–262.
Santos, A., Humayun, M. S., de Juan Jr., E., Greenberg, R. J.,
Marsh, M. J., Klock, I. B., & Milam, A. H. (1997). Preservation
of the inner retina in retinitis pigmentosa. A morphometric analy-
sis. Archi6es of Ophthalmology, 115, 511–515.
Sarthy, P. V., & Fu, M. (1989). Transcriptional activation of an
intermediate filament protein gene in mice with retinal dystrophy.
DNA, 8, 437–446.
Schmidt, E. M., Bak, M., Hambrecht, F. T., Kufta, C. V., O’Rourke,
D. K., & Vallabhanath, P. (1996). Feasibility of a visual prosthe-
sis for the blind based on intracortical microstimulation of the
visual cortex. Brain, 119, 507–522.
Schubert, M.B., Hierzenberger, A., Wanka, H.N., Graf, H.G., Graf,
M., & Nisch, W. (1997). Flexible micro-photodiode array as a
subretinal implant. Proceedings of the 27th European Solid-State
De6ice Research Conference (ESSDERC) (pp. 444). Stuttgart,
Germany.
Seiler, M. J., & Aramant, R. B. (1999). Intact sheets of fetal retina
transplanted to restore damaged rat retinas. In6estigati6e Ophthal-
mology and Visual Science, 39, 2121–2132.
Seiler, M., & Turner, J. E. (1988). The activities of host and graft glial
cells following retinal transplantation into the lesioned adult rat
eye: developmental expression of glial markers. De6elopmental
Brain Research, 43, 111–122..
E. Zrenner et al. : Vision Research 39 (1999) 2555–2567 2567
Sheedlo, H. J., Gaur, V., Li, L. X., Seaton, A. D., & Turner, J. E.
(1991). Transplantation to the diseased and damaged retina.
Trends in Neuroscience, 14, 347–350.
Smith, S. B., Brodjian, S., Desai, S., & Sarthy, V. (1997). Glial
fibrillary acidic 1,protein (GFAP) is synthesized in the early stages
of the photoreceptor cell degeneration of the mivit:mivit (vitiligo)
mouse. Experimental Eye Research, 64(4), 645–650.
Stett, A., Weiss, S., Gnauck, P., Stelzle, M., Nisch, W., Haemmerle,
H., & Zrenner, E. (1997). Towards a subretinal implant: investiga-
tions of the chip:retina interface. In6estigati6e Ophthalmology and
Visual Science, 38, S41 (Abstract).
Stett, A., Kohler, K., Weiss, S., Haemmerle, H., & Zrenner, E.
(1998). Electrical stimulation of degenerated retina of RCS rats by
distally applied spatial voltage patterns. In6estigati6e Ophthalmol-
ogy and Visual Science, 39, S162 (Abstract).
Tassiker, G.E. (1956). Retinal stimulator. US Patent No. 2,760,483.
Troeger, B., Guenther, E., Schlosshauer, B., Hoff, A., & Zrenner, E.
(1997). Biocompatibility and long-term stability of components of
a multi-photodiode array intended for subretinal implantation.
In6estigati6e Ophthalmology and Visual Science, 38, S40 (Ab-
stract).
Troy, J. B., & Lee, B. B. (1994). Steady discharges of macaque retinal
ganglion cells. Visual Neuroscience, 11, 111–118.
Troy, J. B., & Robson, J. G. (1992). Steady discharges of X and Y
retinal ganglion cells of cat under photopic illuminance. Visual
Neuroscience, 9, 535–553.
Tyler, N. K., & Burns, M. S. (1991). Alterations in glial cell morphol-
ogy and glial fibrillary acidic protein expression in urethane-in-
duced retinopathy. In6estigati6e Ophthalmology and Visual
Science, 32, 246–256.
Weiss, S., Herrmann, T., Kohler, K., Stett, A., & Haemmerle, H.
(1998). Spontaneous and electrically evoked spatio-temporal firing
patterns in the RCS rat retina. In6estigati6e Ophthalmology and
Visual Science, 39, S991 (Abstract).
Wyatt, J., & Rizzo, J. (1996). Ocular implants for the blind. IEEE
Spectrum, 33, 47–53.
Zrenner, E., Miliczek, K.-D., Gabel, V. P., Graf, H. G., Guenther,
E., Haemmerle, H., Hoefflinger, B., Kohler, K., Nisch, W., Schu-
bert, M., Stett, A., & Weiss, S. (1997). The development of
subretinal microphotodiodes for replacement of degenerated pho-
toreceptors. Ophthalmic Research, 29, 269–280.
.
